Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tagrisso
Tagrisso
AstraZeneca’s Tagrisso Continues to Make Strides in Phase III Lung Cancer Trial
BioSpace
Tue, 09/22/20 - 11:10 am
AstraZeneca
clinical trials
Tagrisso
ESMO
non-small cell lung cancer
#ESMO20: AstraZeneca burnishes Tagrisso's adjuvant NSCLC profile with 'unprecedented' reduction in brain mets. Can they win over skeptics?
Endpoints
Sat, 09/19/20 - 09:05 pm
AstraZeneca
Tagrisso
non-small cell lung cancer
ESMO
Daiichi Sankyo, AstraZeneca collaborate to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC
Pharmaceutical Business Review
Fri, 08/7/20 - 11:10 am
Daiichi Sankyo
AstraZeneca
patritumab deruxtecan
Tagrisso
non-small cell lung cancer
clinical trials
Cut-price drug venture takes aim at Pfizer and Astrazeneca
EP Vantage
Fri, 07/24/20 - 09:27 am
Pfizer
AstraZeneca
EQRx
drug pricing
Ibrance
Tagrisso
In pilot of patient-reported outcomes project, FDA hopes to encourage ‘more rigorous’ data collection
MedCity News
Sun, 06/28/20 - 06:56 pm
AstraZeneca
clinical trials
Tagrisso
FDA
lung cancer
patients
ASCO 2020 round-up: Virtual conference still delivers the drama ASCO 2020 round-up: Virtual conference still delivers the drama
Pharmaforum
Fri, 06/5/20 - 10:30 am
ASCO 2020
Amgen
AstraZeneca
Bristol-Myers Squibb
cancer
CAR-T
COVID-19
Keytruda
Kyprolis
Tagrisso
AstraZeneca's Blockbuster Lung Cancer Drug Has a Huge Sales Boost Ahead
Motley Fool
Sat, 05/30/20 - 07:48 pm
AstraZeneca
ASCO 2020
lung cancer
adjuvants
Tagrisso
AstraZeneca bid to expand lung cancer drug's use boosted by trial data
BioPharma Dive
Thu, 05/28/20 - 11:12 pm
AstraZeneca
Tagrisso
lung cancer
clinical trials
ASCO 2020
AstraZeneca to unveil key data for cancer drugs at ASCO
Pharmaforum
Fri, 05/15/20 - 10:41 am
AstraZeneca
ASCO 2020
Tagrisso
lung cancer
Enhertu
breast cancer
gastric cancer
colorectal cancer
AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy
Endpoints
Mon, 04/13/20 - 11:06 am
AstraZeneca
Tagrisso
clinical trials
non-small cell lung cancer
Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful
Fierce Pharma
Mon, 10/7/19 - 12:18 pm
EGFR lung cancer
lung cancer
Eli Lilly
Cyramza
AstraZeneca
Tagrisso
ESMO: AstraZeneca eyes payer boost with Tagrisso's latest survival win
Fierce Pharma
Sun, 09/29/19 - 09:29 pm
AstraZeneca
Tagrisso
EGFR lung cancer
ESMO
AZ gets China nod for Tagrisso in first-line lung cancer
Pharmaforum
Wed, 09/4/19 - 11:22 am
AstraZeneca
China
Tagrisso
non-small cell lung cancer
AstraZeneca cancer drugs build as primary care shrinks
Biopharma Dive
Mon, 08/12/19 - 12:08 pm
AstraZeneca
cancer
oncology
primary care
Tagrisso
Symbicort
Lynparza
AstraZeneca's flagship Tagrisso helps lung cancer patients live longer in pivotal study
Endpoints
Fri, 08/9/19 - 10:28 am
AstraZeneca
Tagrisso
EGFR-mutated NSCLC
Chi-Med, AstraZeneca's savolitinib helps some Tagrisso-resistant EGFR lung cancer patients
Fierce Pharma
Sun, 03/31/19 - 03:44 pm
Chi-Med
savolitinib
AstraZeneca
Tagrisso
EGFR lung cancer
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
Fri, 12/28/18 - 01:30 pm
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
In another try at lung cancer niche, J&J nabs a potential Tagrisso rival for $50M-plus
Endpoints
Mon, 11/5/18 - 07:17 pm
JNJ
Tagrisso
AstraZeneca
Yuhan
Major Expected Events from AstraZeneca’s R&D in H2 2018
Market Realist
Sat, 08/25/18 - 09:24 pm
AstraZeneca
China
Lynparza
Tagrisso
Imfinzi
AstraZeneca gets further approval for Tagrisso in Japan
Pharmaforum
Tue, 08/21/18 - 10:08 am
AstraZeneca
Japan
Tagrisso
non-small cell lung cancer
Pages
« first
‹ previous
1
2
3
next ›
last »